NCT02265133

Brief Summary

This study is a prospective, single center clinical trial to assess corneal sensitivity and nerve fiber morphology in patients with sleep apnea compared to normal controls. Healthy volunteers with no history of ocular or uncontrollable systemic disease will be encouraged to participate in the study. After execution and review of the consenting procedures, a detailed history will be taken and a slit lamp examination performed, verifying ocular health. This consists of an examination of both eyes including assessments of ocular lids, lashes, cornea and conjunctival evaluation. Corneal touch thresholds will be tested with a Cochet-Bonnet aesthesiometer, a standard non-invasive measure of corneal sensitivity. Corneal nerves will be imaged using a modified HRT in vivo confocal microscope. The in vivo confocal microscope allows for high resolution imaging of the nerve plexus under the corneal epithelium. This corneal nerve plexus is responsible for corneal sensitively and changes or loss have been established as an early, sensitive indicator of corneal neuropathy. The investigators anticipate that this study will require approximately 30 patients for each group and will last approximately 12 months for recruitment and completion of subject visit phases. There is only one clinical visit designed for this project, unscheduled visits may be scheduled in case of an adverse event. Patient recruitment will be complete at the one-year time point. At the 14 month time point, all data points will have been collected and assessment of the outcome measure (corneal sensitivity in sleep apnea patients versus control patients) will be complete.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2015

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2011

Completed
2.8 years until next milestone

First Posted

Study publicly available on registry

October 15, 2014

Completed
9 months until next milestone

Study Start

First participant enrolled

July 17, 2015

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2024

Completed
Last Updated

August 21, 2024

Status Verified

August 1, 2024

Enrollment Period

7 years

First QC Date

December 21, 2011

Last Update Submit

August 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Corneal Sensitivity

    To investigate whether diminished corneal sensitivity contributes to corneal problems commonly reported in patients with sleep apnea. Specifically, this study will correlate changes in corneal touch thresholds with corneal nerve fiber morphology using in vivo confocal microscopy.

    1-Day

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Sleep Apnea and normal controls

You may qualify if:

  • Healthy, non-smoking volunteers.
  • Patients with a diagnosis of sleep apnea.
  • Non-contact lens wearers of any gender and race, ages 18 and up.
  • Minority representation will be proactively encouraged.
  • Patients that are willing to review, understand, and sign the written Informed Consent.
  • Written authorization for use or release of health and research study information.
  • Patients that are willing and able to cooperate with the Investigator and follow all instructions.

You may not qualify if:

  • Use of ocular drops including over the counter (OTC) dry eye drops.
  • Previous history of corneal surgery.
  • Previous history of ocular trauma.
  • History of Diabetes Mellitus.
  • Current active or previous history of Herpes virus keratitis.
  • Current or former Contact lens wear.
  • Chronic history of dry eye disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Parkland Hospital

Dallas, Texas, 75235, United States

Location

Aston Ambulatory Care Center

Dallas, Texas, 75390, United States

Location

MeSH Terms

Conditions

Sleep Apnea Syndromes

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Danielle Robertson, O.D, PhD

    UTSW Medical Center at Dallas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

December 21, 2011

First Posted

October 15, 2014

Study Start

July 17, 2015

Primary Completion

July 1, 2022

Study Completion

August 20, 2024

Last Updated

August 21, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations